According to the ETF Finder at ETF Channel, BMRN makes up 4.39% of the Biotech ETF (BBH) which is up by about 2.5% on the day Wednesday.
In afternoon trading Wednesday, BMRN was up about 2.1% on the day.
BioMarin (BMRN) stock was trading sharply higher this morning after Pfizer (PFE) beat out Sanofi (SNY) to purchase Medivation (MDVN).
Overall, this is still a good environment for stock picking.
BioMarin (BMRN) stock is trading lower after the market close after announcing a public offering of common stock.